Scailyte AG

Scailyte AG

Private
BaselHealthcare & Life Scienceshttps://www.scailyte.com/

Last Round

Series A

Extension

Dec 4, 2023

Total Funding Raised

$14.04M

Company Overview

Scailyte AG is a biotechnology company that provides an artificial intelligence platform for the discovery of complex disease patterns from single-cell data.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Subscription SaaS

AI Layer

Application

Keywords

biomarker discoverysingle-cell analysisAI drug discoverypatient stratificationCDxcompanion diagnosticsprecision medicinespatial omicsbiotech AImulti-omicsclinical trial optimizationoncologyimmunologyInflammatory Bowel DiseaseIBD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scailyte AG Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Scailyte AG Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionDec 4, 2023
Series ASep 21, 2022
SeedJun 9, 2020
SeedDec 19, 2018

Key People

Founding team and executive leadership

Peter Nestorov

Co-Founder And CEO

Founding Team

Scailyte AG Investors

Notable investors and investment history

InvestorRounds
Swisscom VenturesSeries A, Seed
4FOX VenturesSeries A, Seed
Venture KickGrant
Mirabaud SecuritiesSeries A
Zurcher KantonalbankSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2025

    Monthly visitors increased 136% MoM, reaching 2.6K.

  • Nov 14, 2024

    Monthly visitors increased 98% MoM.

Scailyte AG Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Scailyte AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Scailyte AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel
Employee Range19
Year Founded2017
Last FundingDec 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.